MBRS-34. MOLECULAR CHARACTERIZATION OF RECURRENT MEDULLOBLASTOMA REVEALS AN UNEXPECTEDLY HIGH INCIDENCE OF SECONDARY MALIGNANCY

INTRODUCTION: Despite an overall 5-year progression free survival of approximately 80% for primary medulloblastomas (MBs), recurrent disease confers an abysmal prognosis with less than 10% 5-year survival. Subgroup affiliation at recurrence has been reported as stable though divergent clonal selecti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Kumar, Rahul, Deng, Maximilian, Rudneva, Vasilisa A, Robinson, Giles W, Dhall, Girish, Klesse, Laure J, Bowers, Daniel C, Chintagumpala, Murali, Leary, Sarah, Orr, Brent A, Pfister, Stefan M, Gajjar, Amar, Jones, David T W, Northcott, Paul A
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012936/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.479
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados